We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
115 hedge funds and large institutions have $445M invested in Lexicon Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 13
88% more call options, than puts
Call options by funds: $1.74M | Put options by funds: $928K
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more capital invested
Capital invested by funds: $308M → $445M (+$136M)
12% more funds holding
Funds holding: 103 → 115 (+12)
4.47% more ownership
Funds ownership: 96.38% → 100.86% (+4.5%)
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
Holders
115
Holders Change
+12
Holders Change %
+11.65%
% of All Funds
2.27%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
26
Increased
31
Reduced
32
Closed
13
Calls
$1.74M
Puts
$928K
Net Calls
+$816K
Net Calls Change
+$951K
Top Buyers
| 1 |
Two Sigma Investments
New York
|
+$3.33M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$3.28M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$2.67M |
| 4 |
Bank of New York Mellon
New York
|
+$2.35M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.1M |
